RT @EricTopol: So much to learn about #Parkinsonsdisease, which is on a steep rise. Here a @CedarsSinai made iPSCs from individuals w/ youn…
#NatureMedicine iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates https://t.co/RhYUV2vXYL
RT @EricTopol: So much to learn about #Parkinsonsdisease, which is on a steep rise. Here a @CedarsSinai made iPSCs from individuals w/ youn…
RT @EricTopol: So much to learn about #Parkinsonsdisease, which is on a steep rise. Here a @CedarsSinai made iPSCs from individuals w/ youn…
Cool article on disease modelling using iPSCs! https://t.co/YXML3ax0u7
Re. Any differences in your assay DNA does not override that similarity https://t.co/9ONdHM8zlv We'll continue to override the issues of perception and will continue to work twice as hard as everyone else.
RT @EricTopol: So much to learn about #Parkinsonsdisease, which is on a steep rise. Here a @CedarsSinai made iPSCs from individuals w/ youn…
RT @EricTopol: So much to learn about #Parkinsonsdisease, which is on a steep rise. Here a @CedarsSinai made iPSCs from individuals w/ youn…
So much to learn about #Parkinsonsdisease, which is on a steep rise. Here a @CedarsSinai made iPSCs from individuals w/ young subtype, w/ results suggesting prolonged cell dysfunction antedating disease, and drug Rx potential https://t.co/w4ed6a8Vba @Natur